日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification

MDM2 与靶向激酶抑制剂联合使用可延长具有致癌酪氨酸激酶驱动和 MDM2 扩增的肺腺癌的肿瘤控制时间

Arielle Elkrief, Igor Odintsov, Roger S Smith, Morana Vojnic, Takuo Hayashi, Inna Khodos, Vladimir Markov, Zebing Liu, Allan J W Lui, Jamie L Bloom, Michael D Offin, Charles M Rudin, Elisa de Stanchina, Gregory J Riely, Romel Somwar, Marc Ladanyi

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

维帕替尼是一种药理学上先进的 RET 选择性抑制剂,具有较高的中枢神经系统渗透性和对 RET 溶剂前沿突变的抑制活性

Isao Miyazaki #, Igor Odintsov #, Keiji Ishida, Allan J W Lui, Masanori Kato, Tatsuya Suzuki, Tom Zhang, Kentaro Wakayama, Renate I Kurth, Ryan Cheng, Hidenori Fujita, Lukas Delasos, Morana Vojnic, Inna Khodos, Yukari Yamada, Kota Ishizawa, Marissa S Mattar, Kaoru Funabashi, Qing Chang, Shuichi Ohku

Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification

MDM2 和 MEK 抑制剂联合治疗对同时存在致癌驱动因素和 MDM2 扩增的肺腺癌患者模型有效

Arielle Elkrief, Igor Odintsov, Vladimir Markov, Rebecca Caeser, Pawel Sobczuk, Sam E Tischfield, Umesh Bhanot, Chad M Vanderbilt, Emily H Cheng, Alexander Drilon, Gregory J Riely, William W Lockwood, Elisa de Stanchina, Vijaya G Tirunagaru, Robert C Doebele, Álvaro Quintanal-Villalonga, Charles M R

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma

CIC 介导的 MAPK 信号调节对抗激酶成瘾肉瘤中的受体酪氨酸激酶抑制剂反应

Igor Odintsov, Michael V Ortiz, Inna Khodos, Marissa S Mattar, Allan J W Lui, Shinji Kohsaka, Elisa de Stanchina, Julia L Glade Bender, Marc Ladanyi, Romel Somwar

Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

新型患者衍生的促纤维增生性小圆细胞肿瘤模型证实了对 ERBB 信号的可靶向依赖性

Roger S Smith, Igor Odintsov, Zebing Liu, Allan Jo-Weng Lui, Takuo Hayashi, Morana Vojnic, Yoshiyuki Suehara, Lukas Delasos, Marissa S Mattar, Julija Hmeljak, Hillary A Ramirez, Melissa Shaw, Gabrielle Bui, Alifiani B Hartono, Eric Gladstone, Siddharth Kunte, Heather Magnan, Inna Khodos, Elisa De St

Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation

PI3KCA、GNAS 和 PTEN 突变对伴有 MYOD1 L122R 突变的梭形细胞横纹肌肉瘤的功能影响和靶向性

Florence Choo, Igor Odintsov, Kevin Nusser, Katelyn S Nicholson, Lara Davis, Christopher L Corless, Linda Stork, Romel Somwar, Marc Ladanyi, Jessica L Davis, Monika A Davare

Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor

NTRK3 抑制对促纤维增生性小圆细胞肿瘤的治疗潜力

Koichi Ogura #, Romel Somwar #, Julija Hmeljak #, Heather Magnan, Ryma Benayed, Amir Momeni Boroujeni, Anita S Bowman, Marissa S Mattar, Inna Khodos, Elisa de Stanchina, Achim Jungbluth, Marina Asher, Igor Odintsov, Alifiani B Hartono, Michael P LaQuaglia, Emily Slotkin, Christine A Pratilas, Sean B

NTRK kinase domain mutations in cancer variably impact sensitivity to type I and type II inhibitors

癌症中的 NTRK 激酶结构域突变对 I 型和 II 型抑制剂的敏感性有不同影响

Romel Somwar, Nicolle E Hofmann, Bryan Smith, Igor Odintsov, Morana Vojnic, Irina Linkov, Ashley Tam, Inna Khodos, Marissa S Mattar, Elisa de Stanchina, Daniel Flynn, Marc Ladanyi, Alexander Drilon, Ujwal Shinde, Monika A Davare

RET inhibition in novel patient-derived models of RET-fusion positive lung adenocarcinoma reveals a role for MYC upregulation

在 RET 融合阳性肺腺癌患者新模型中抑制 RET 可揭示 MYC 上调的作用

Takuo Hayashi, Igor Odintsov, Roger S Smith, Kota Ishizawa, Allan J W Liu, Lukas Delasos, Christopher Kurzatkowski, Huichun Tai, Eric Gladstone, Morana Vojnic, Shinji Kohsaka, Ken Suzawa, Zebing Liu, Siddharth Kunte, Marissa S Mattar, Inna Khodos, Monika A Davare, Alexander Drilon, Emily Cheng, Elis